Evolyzer
Latest round
- Series B
Last raised
- Mar 2025
Total raised
- $28M
Investors
- 10
About Evolyzer
Established in 2022 and based in Beijing, China, Evolyzer operates as a biotechnology company dedicated to the research and development of synthetic biology. It has production bases in Shandong and Hangzhou. The company's founder and chief scientist officer (CSO), Dr. Huimin Yu, is a professor in the Department of Chemical Engineering at Tsinghua University. The company has obtained 21 invention patents and acquired certifications such as ISO9001, ISO14001, and ISO45001. The company provides agricultural and food solutions, energy and chemical solutions, daily chemical and medical beauty solutions, and medical and pharmaceutical solutions. The agricultural and food solutions is green agricultural products with biological activation factors as the core, which provides water-soluble fertilizers, microbial agents, and bio-synergists. Evolyzer also provides business biocatalysts, bio-templated nano and single-atom metal catalysts, and specialty chemicals. The products can be used in agriculture, daily chemicals, medicine and other fields. The company generates revenue by providing chemicals and solutions developed through biotechnology such as agricultural and food solutions and energy and chemical solutions.
Who invested in Evolyzer
10 investors across 4 rounds
See all investors in Evolyzer
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Evolyzer
Who invested in Evolyzer?
Evolyzer has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Evolyzer raised?
Evolyzer has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Evolyzer last raise money?
Evolyzer's most recent round on record is a Series B, in Mar 2025.
What does Evolyzer do?
Established in 2022 and based in Beijing, China, Evolyzer operates as a biotechnology company dedicated to the research and development of synthetic biology.
Where is Evolyzer headquartered?
Evolyzer is headquartered in Beijing, China.
Which VCs invest in companies like Evolyzer?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Evolyzer's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Evolyzer? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.